 Suzanne Lareau
Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 30 | 2022 | 919 | 3.840 |
Why?
| | Dyspnea | 14 | 2021 | 250 | 1.360 |
Why?
| | Fatigue | 4 | 2023 | 363 | 0.890 |
Why?
| | Patient Education as Topic | 7 | 2018 | 775 | 0.840 |
Why?
| | Medication Adherence | 3 | 2016 | 540 | 0.840 |
Why?
| | Lung Diseases | 6 | 2021 | 780 | 0.830 |
Why?
| | Exercise Therapy | 6 | 2016 | 475 | 0.760 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2021 | 121 | 0.620 |
Why?
| | Activities of Daily Living | 8 | 2019 | 439 | 0.600 |
Why?
| | Cardiac Rehabilitation | 1 | 2020 | 46 | 0.590 |
Why?
| | Lung Diseases, Obstructive | 6 | 1999 | 43 | 0.590 |
Why?
| | Motor Activity | 3 | 2020 | 718 | 0.530 |
Why?
| | Disability Evaluation | 1 | 2019 | 310 | 0.500 |
Why?
| | Smoking Cessation | 2 | 2021 | 437 | 0.480 |
Why?
| | Bronchodilator Agents | 4 | 2019 | 187 | 0.480 |
Why?
| | Respiration | 1 | 2017 | 206 | 0.470 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2022 | 1188 | 0.470 |
Why?
| | Patient Compliance | 2 | 2020 | 587 | 0.460 |
Why?
| | Self Care | 3 | 2016 | 388 | 0.460 |
Why?
| | Health Education | 1 | 2018 | 345 | 0.450 |
Why?
| | Oxygen Inhalation Therapy | 3 | 2016 | 181 | 0.450 |
Why?
| | Goals | 1 | 2017 | 184 | 0.440 |
Why?
| | Nebulizers and Vaporizers | 2 | 2011 | 62 | 0.430 |
Why?
| | Respiration Disorders | 3 | 2023 | 78 | 0.430 |
Why?
| | Patient Reported Outcome Measures | 1 | 2018 | 497 | 0.410 |
Why?
| | Health Status | 3 | 2018 | 832 | 0.400 |
Why?
| | Respiration, Artificial | 3 | 2017 | 713 | 0.400 |
Why?
| | Telemedicine | 2 | 2020 | 956 | 0.390 |
Why?
| | Quality of Life | 9 | 2021 | 3194 | 0.380 |
Why?
| | Disease Progression | 4 | 2018 | 2857 | 0.350 |
Why?
| | Heart Failure | 3 | 2020 | 2324 | 0.340 |
Why?
| | Lung Neoplasms | 2 | 2022 | 2662 | 0.340 |
Why?
| | Humans | 54 | 2023 | 145140 | 0.310 |
Why?
| | Frailty | 2 | 2023 | 203 | 0.300 |
Why?
| | Pamphlets | 2 | 2018 | 26 | 0.280 |
Why?
| | Surveys and Questionnaires | 11 | 2019 | 6055 | 0.280 |
Why?
| | Delivery of Health Care, Integrated | 3 | 2018 | 299 | 0.260 |
Why?
| | Glucocorticoids | 1 | 2011 | 531 | 0.260 |
Why?
| | Critical Care | 1 | 2012 | 702 | 0.240 |
Why?
| | Health Status Indicators | 3 | 2008 | 167 | 0.220 |
Why?
| | Critical Illness | 3 | 2018 | 899 | 0.220 |
Why?
| | Metered Dose Inhalers | 2 | 2014 | 8 | 0.200 |
Why?
| | Self-Assessment | 1 | 2004 | 74 | 0.200 |
Why?
| | Pneumonectomy | 2 | 2021 | 167 | 0.190 |
Why?
| | Respiratory Tract Diseases | 2 | 2023 | 175 | 0.190 |
Why?
| | Telerehabilitation | 1 | 2023 | 46 | 0.180 |
Why?
| | Exercise Tolerance | 4 | 2014 | 283 | 0.180 |
Why?
| | Chemoradiotherapy, Adjuvant | 1 | 2021 | 44 | 0.180 |
Why?
| | Terminology as Topic | 1 | 2004 | 256 | 0.170 |
Why?
| | Walking | 1 | 2006 | 542 | 0.160 |
Why?
| | Reproducibility of Results | 6 | 2019 | 3410 | 0.160 |
Why?
| | Societies, Medical | 4 | 2018 | 898 | 0.160 |
Why?
| | Karnofsky Performance Status | 1 | 2019 | 37 | 0.140 |
Why?
| | Interdisciplinary Studies | 1 | 2018 | 30 | 0.140 |
Why?
| | Respiratory Therapy | 1 | 2018 | 25 | 0.140 |
Why?
| | Education | 1 | 2018 | 104 | 0.140 |
Why?
| | Adrenal Cortex Hormones | 2 | 2019 | 483 | 0.140 |
Why?
| | Practice Guidelines as Topic | 2 | 2016 | 1579 | 0.130 |
Why?
| | Medical History Taking | 1 | 1998 | 117 | 0.130 |
Why?
| | Neoplasm Staging | 1 | 2021 | 1467 | 0.130 |
Why?
| | Spirometry | 1 | 1998 | 233 | 0.130 |
Why?
| | Equipment and Supplies | 1 | 2017 | 36 | 0.130 |
Why?
| | Psychometrics | 2 | 2019 | 731 | 0.130 |
Why?
| | Smoking | 2 | 2021 | 1470 | 0.130 |
Why?
| | Muscarinic Antagonists | 1 | 2017 | 30 | 0.130 |
Why?
| | Administration, Inhalation | 3 | 2017 | 571 | 0.130 |
Why?
| | Early Detection of Cancer | 1 | 2021 | 482 | 0.120 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2017 | 90 | 0.120 |
Why?
| | Drug Monitoring | 1 | 2020 | 399 | 0.120 |
Why?
| | Lung | 5 | 2019 | 4101 | 0.120 |
Why?
| | Severity of Illness Index | 4 | 2018 | 2928 | 0.120 |
Why?
| | Comorbidity | 2 | 2022 | 1657 | 0.110 |
Why?
| | Tonsillectomy | 1 | 2017 | 105 | 0.110 |
Why?
| | Education, Medical | 1 | 2018 | 274 | 0.110 |
Why?
| | Advisory Committees | 1 | 2016 | 229 | 0.110 |
Why?
| | United States | 10 | 2023 | 16065 | 0.100 |
Why?
| | Palliative Care | 2 | 2023 | 1017 | 0.100 |
Why?
| | Risk Factors | 3 | 2021 | 10857 | 0.100 |
Why?
| | Evidence-Based Medicine | 2 | 2016 | 739 | 0.100 |
Why?
| | Patient Safety | 1 | 2017 | 355 | 0.100 |
Why?
| | Pulmonary Medicine | 1 | 2013 | 78 | 0.100 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2017 | 302 | 0.090 |
Why?
| | Aged | 10 | 2023 | 26096 | 0.090 |
Why?
| | History, 19th Century | 1 | 2012 | 63 | 0.090 |
Why?
| | Self Efficacy | 1 | 2016 | 410 | 0.090 |
Why?
| | Health Policy | 1 | 2015 | 400 | 0.090 |
Why?
| | Myocardial Infarction | 1 | 2020 | 1210 | 0.090 |
Why?
| | Nursing | 1 | 2012 | 37 | 0.090 |
Why?
| | Sleep Wake Disorders | 1 | 2016 | 310 | 0.090 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2012 | 98 | 0.090 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 1321 | 0.080 |
Why?
| | Affective Symptoms | 1 | 2011 | 53 | 0.080 |
Why?
| | Irritable Mood | 1 | 2011 | 50 | 0.080 |
Why?
| | History, 20th Century | 1 | 2012 | 327 | 0.080 |
Why?
| | Education, Nursing | 1 | 2012 | 91 | 0.080 |
Why?
| | Motor Skills | 1 | 2011 | 104 | 0.080 |
Why?
| | Italy | 2 | 2022 | 114 | 0.080 |
Why?
| | Intensive Care Units | 1 | 2017 | 924 | 0.080 |
Why?
| | Forced Expiratory Volume | 3 | 2008 | 450 | 0.080 |
Why?
| | Evidence-Based Practice | 1 | 2012 | 231 | 0.080 |
Why?
| | Exercise Test | 3 | 2010 | 626 | 0.080 |
Why?
| | Nurse Practitioners | 1 | 2011 | 138 | 0.070 |
Why?
| | Gastroesophageal Reflux | 1 | 2011 | 236 | 0.070 |
Why?
| | Acute Lung Injury | 1 | 2012 | 305 | 0.070 |
Why?
| | Tuberculosis | 1 | 2012 | 283 | 0.070 |
Why?
| | Respiratory Function Tests | 4 | 2008 | 543 | 0.070 |
Why?
| | Europe | 3 | 2015 | 416 | 0.070 |
Why?
| | Exercise | 1 | 2020 | 2191 | 0.070 |
Why?
| | Health Services Accessibility | 1 | 2016 | 1099 | 0.070 |
Why?
| | Cognition Disorders | 1 | 2011 | 539 | 0.060 |
Why?
| | Treatment Outcome | 6 | 2018 | 11741 | 0.060 |
Why?
| | Middle Aged | 7 | 2018 | 36126 | 0.060 |
Why?
| | Physician-Patient Relations | 1 | 2010 | 587 | 0.060 |
Why?
| | Burnout, Professional | 1 | 2012 | 486 | 0.060 |
Why?
| | Video Recording | 1 | 2006 | 217 | 0.050 |
Why?
| | Metaphor | 1 | 2004 | 5 | 0.050 |
Why?
| | Psycholinguistics | 1 | 2004 | 20 | 0.050 |
Why?
| | Work of Breathing | 1 | 2003 | 3 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2018 | 8318 | 0.050 |
Why?
| | Monitoring, Physiologic | 1 | 2006 | 288 | 0.050 |
Why?
| | Self Disclosure | 1 | 2003 | 61 | 0.050 |
Why?
| | Longitudinal Studies | 3 | 2003 | 2949 | 0.050 |
Why?
| | Chronic Disease | 3 | 2015 | 1806 | 0.050 |
Why?
| | Male | 11 | 2022 | 72664 | 0.050 |
Why?
| | Frail Elderly | 1 | 2023 | 136 | 0.050 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2010 | 1415 | 0.040 |
Why?
| | Adult | 3 | 2018 | 40665 | 0.040 |
Why?
| | Risk Assessment | 1 | 2010 | 3740 | 0.040 |
Why?
| | Theophylline | 1 | 2019 | 41 | 0.040 |
Why?
| | Adrenergic beta-2 Receptor Agonists | 1 | 2019 | 26 | 0.040 |
Why?
| | Cholinergic Antagonists | 1 | 2019 | 24 | 0.040 |
Why?
| | New Zealand | 1 | 2018 | 54 | 0.030 |
Why?
| | Time Factors | 2 | 2018 | 7107 | 0.030 |
Why?
| | Australia | 1 | 2018 | 287 | 0.030 |
Why?
| | Program Evaluation | 2 | 2013 | 943 | 0.030 |
Why?
| | Canada | 1 | 2018 | 429 | 0.030 |
Why?
| | Breathing Exercises | 2 | 2006 | 21 | 0.030 |
Why?
| | Congresses as Topic | 1 | 2018 | 223 | 0.030 |
Why?
| | Evaluation Studies as Topic | 1 | 1996 | 164 | 0.030 |
Why?
| | Polysomnography | 1 | 2017 | 239 | 0.030 |
Why?
| | Lung Transplantation | 1 | 2019 | 329 | 0.030 |
Why?
| | Patient Acceptance of Health Care | 1 | 2022 | 881 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2022 | 946 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2018 | 640 | 0.030 |
Why?
| | Positive-Pressure Respiration | 1 | 1976 | 115 | 0.030 |
Why?
| | Patient Selection | 1 | 2019 | 733 | 0.030 |
Why?
| | Health Care Costs | 1 | 2018 | 425 | 0.030 |
Why?
| | Forced Expiratory Flow Rates | 1 | 1994 | 10 | 0.030 |
Why?
| | Total Lung Capacity | 1 | 1994 | 29 | 0.030 |
Why?
| | Rehabilitation | 1 | 2013 | 20 | 0.020 |
Why?
| | Ambulatory Care | 1 | 1998 | 608 | 0.020 |
Why?
| | International Cooperation | 1 | 2013 | 197 | 0.020 |
Why?
| | Models, Organizational | 1 | 2013 | 144 | 0.020 |
Why?
| | North America | 1 | 2013 | 301 | 0.020 |
Why?
| | Prognosis | 2 | 2008 | 4310 | 0.020 |
Why?
| | Reference Values | 1 | 1994 | 798 | 0.020 |
Why?
| | Benchmarking | 1 | 2013 | 188 | 0.020 |
Why?
| | Disease Management | 1 | 2016 | 651 | 0.020 |
Why?
| | Guideline Adherence | 1 | 2016 | 586 | 0.020 |
Why?
| | Asthma | 1 | 2003 | 1795 | 0.020 |
Why?
| | Pediatric Nursing | 1 | 2011 | 44 | 0.020 |
Why?
| | Oxygen | 1 | 1976 | 978 | 0.020 |
Why?
| | Proton Pump Inhibitors | 1 | 2011 | 109 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2458 | 0.020 |
Why?
| | Female | 6 | 2018 | 78636 | 0.020 |
Why?
| | Taiwan | 1 | 2008 | 48 | 0.020 |
Why?
| | Brazil | 1 | 2008 | 179 | 0.020 |
Why?
| | Reference Standards | 1 | 2008 | 177 | 0.020 |
Why?
| | Cross-Cultural Comparison | 1 | 2008 | 84 | 0.020 |
Why?
| | China | 1 | 2008 | 269 | 0.020 |
Why?
| | Referral and Consultation | 1 | 2013 | 862 | 0.020 |
Why?
| | Relaxation Therapy | 1 | 1987 | 19 | 0.020 |
Why?
| | Nursing Assessment | 1 | 1987 | 53 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2008 | 368 | 0.020 |
Why?
| | Respiratory Muscles | 1 | 2006 | 37 | 0.010 |
Why?
| | Social Support | 1 | 2010 | 645 | 0.010 |
Why?
| | Posture | 1 | 1987 | 197 | 0.010 |
Why?
| | Sickness Impact Profile | 1 | 2005 | 62 | 0.010 |
Why?
| | Language | 1 | 2008 | 322 | 0.010 |
Why?
| | Patient-Centered Care | 1 | 2010 | 547 | 0.010 |
Why?
| | Survival Analysis | 1 | 2008 | 1371 | 0.010 |
Why?
| | Quality Assurance, Health Care | 1 | 2006 | 342 | 0.010 |
Why?
| | Program Development | 1 | 2006 | 368 | 0.010 |
Why?
| | Energy Intake | 1 | 2006 | 507 | 0.010 |
Why?
| | Analgesics, Opioid | 1 | 2012 | 1145 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2008 | 2115 | 0.010 |
Why?
| | Respiratory Insufficiency | 1 | 2006 | 326 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2003 | 427 | 0.010 |
Why?
| | Heart | 1 | 2006 | 626 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 2003 | 527 | 0.010 |
Why?
| | Body Composition | 1 | 2006 | 690 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2011 | 5411 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2003 | 1300 | 0.010 |
Why?
| | Data Collection | 1 | 2003 | 639 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 3892 | 0.010 |
Why?
| | Anxiety | 1 | 2006 | 1117 | 0.010 |
Why?
| | Infant | 1 | 2011 | 10060 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2008 | 5886 | 0.010 |
Why?
| | Depression | 1 | 2006 | 1537 | 0.010 |
Why?
| | Partial Pressure | 1 | 1976 | 30 | 0.010 |
Why?
| | Methods | 1 | 1976 | 68 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2006 | 1789 | 0.010 |
Why?
| | Arteries | 1 | 1976 | 261 | 0.010 |
Why?
|
|
Lareau's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|